Tower Research Capital LLC TRC Invests $47,000 in Upstream Bio, Inc. (NASDAQ:UPB)
Tower Research Capital LLC TRC purchased a new position in Upstream Bio, Inc. (NASDAQ:UPB – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,846 shares of the company’s stock, valued at approximately $47,000. A number of other hedge funds […]
